维普中文期刊产品整合服务
103篇 您的检索式:作者名="PISTROSCH F"
    题名 作者 年代 出处 被引量
1PPAR-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells显示文摘Pistrosch F Herbrig K Oelschlaegel U 2005Atherosclerosis2005,183,:1
2Rosiglitazone improvesglomeular hyper filteration,renal endothelial dysfunction,andmicroalbuminuria of incipient diabetic nephropathy inpatients显示文摘Pistrosch F Herbrig K Kindel B 2005Diabetes2005,54,22:1
3In type 2 diabetes, rosiglita-zone therapy for insulin resistance ameliorates endothelial dysfunctionindependent of glucose control 显示文摘F Pistrosch Passauer J Fischer S 2004Diabetes Care2004,27,2:1
4Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity显示文摘Hansel S Lassig G Pistrosch F 2003Atherosclerosis2003,170,1:1
5Conversion of IGT to type 2 diabetes mellitus is associated with incident cases of hypertension: a post-hoc analysis of the STOP-NIDDM trial 显示文摘Hanefeld M Pistrosch F Koehler C 2012J Hypertens2012,30,7:1
6Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodlalysis 显示文摘Herbrig K Pistrosch F Oelschlaegel U 2004Am J Kidney Dis2004,44,5:1
7Rho kinase contributes to basal vascular tone in humans : role of endothelium derived nitric oxide显示文摘Biissemaker E Pistrosch F Frster S 2007Am J Physiol Heart Circ Physiol2007,293,:1
8Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipi- ent diabetic nephropathy in patients显示文摘Pistrosch F Herbrig K Kindel B 2005Diabetes2005,54,7:1
9PPAR'y-agonist increases number and migratory activity of cultured endothelial progenitor cells显示文摘Pistrosch F Herbrig K Oelschlaegel U 2005Atherosclerosis2005,183,1:1
10Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients 显示文摘Pistrosch F Herbrig K Kindel B 2005Diabetes2005,54,7:1
11Rosiglitazoneimproves glomerular hyperfiltration, renal endothelialdysfunction and microalbuminuria of incipient diabecticnephropathy in patients显示文摘Pistrosch F Herbring K Kindle B 2005Diabetes2005,54,7:1
12PPARgammaagonist rusiglitazone increase number and migratory activity of cultured endothelial progenitor cells 显示文摘Pistrosch F Herbrig K Oelschlaegel U 2005Atherosclerosis2005,183,:1
13In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control 显示文摘Pistrosch F Passauer J Fischer S 2004Diabetes Care2004,27,2:1
14Vasopressin antagonists as aquaretie agents for the treatment of hyponatremia 显示文摘Palm C Pistrosch F Herbrig K 2006Am J Med2006,119,71:1
15Rosiglitazone improves glomerular hyperfihratian, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients 显示文摘Pistrosch F Herbrig K Kindel B 2005Diabetes2005,54,7:1
16Rosiglitazone improves glomerular hyperfiltration,renal endothelial dysfunction,and microalbuminuria of incipient diabetic nephropathy in patients显示文摘Pistrosch F Herbrig K Kindel B 2005Diabetes2005,54,7:1
17Rosiglitazone improves glomerular hyper filtration,renal endothelial dysfunction,and microalbuminuria of incipient diabetic nephropathy in patients显示文摘Pistrosch F Herbrig K Kindel B 2005Diabetes2005,54,:1
18Rosiglitazone improves glomerular hyperfiltration,renal endothelial dysfunction,and mieroalbuminutia of incipient diabetic nephropathy in patients显示文摘Pistrosch F Herbrig K Kindel B 2005Diabetes2005,54,7:1
19Rosiglitazone improves glomerular hyperfihration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients显示文摘Pistrosch F Herbrig K Kindel B 2005Diabetes2005,54,7:1
20Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients显示文摘Pistrosch F Reissmann E Wildbrett J 2007Am J Hypertens2007,20,5:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费